Clinical Trials on Pulmonary Multi-drug Resistant Tuberculosis in New Zealand

Total 60 results

Global Alliance for TB Drug Development

Completed

A Phase 1, Drug-Drug Interaction Study of TBAJ-876 in Healthy Adults

Tuberculosis | Tuberculosis, Pulmonary | Pulmonary Disease | Multi Drug Resistant Tuberculosis | Drug Sensitive Tuberculosis | Drug-resistant Tuberculosis | Mycobacterium Tuberculosis Infection

United States
Janssen Infectious Diseases BVBA

Withdrawn

A Study to Evaluate the Efficacy and Safety of TMC207 in Patients With Pulmonary Infection With Multi-drug Resistant Mycobacterium Tuberculosis

Multi-drug Resistant Tuberculosis

China, Ukraine, Taiwan, Korea, Republic of, Peru, Brazil, Estonia, Latvia, Philippines, Russian Federation, South Africa, Thailand, Turkey, Georgia, Mexico, Cambodia, Ethiopia
Centers for Disease Control and Prevention
Columbia University; New York City Department of Health and Mental Hygiene

Completed

An Evaluation of Traditional Directly Observed Therapy (DOT) and Electronic DOT for TB Treatment

Tuberculosis | Adherence, Medication | Drug-resistant Tuberculosis | Adherence, Patient

United States
University of California, Irvine
Harvard Medical School (HMS and HSDM); National Institute of Allergy and Infectious... and other collaborators

Completed

Active Bathing to Eliminate Infection (ABATE Infection) Trial (ABATE)

Methicillin Resistant Staphylococcus Aureus | Multi Drug Resistant Organisms | Healthcare Associated Infections

United States
Icahn School of Medicine at Mount Sinai
National Institute of Mental Health (NIMH)

Recruiting

Electrophysiological Read-Out of Interoceptive Processing

Drug-resistant Epilepsy

United States
Ministry of Science and Technology, India

Unknown

Efficacy of Oral Zinc Administration as an Adjunct Therapy in New Pulmonary Tuberculosis (Category I) Patients

Pulmonary Tuberculosis

India
All India Institute of Medical Sciences, New Delhi
University of Cape Town; Sri Venkateswara Institute of Medical Sciences University

Completed

Intensive Smoking-cessation Intervention Versus Smoking-cessation Advice in Smear-positive Patients With Pulmonary Tuberculosis

Tuberculosis

India
All India Institute of Medical Sciences, New Delhi
University of Bergen

Completed

Micronutrient Supplementation in in Paediatric Pulmonary Tuberculosis (ICTBSG)

Tuberculosis

India
Indian Council of Medical Research
Ministry of Science and Technology, India

Unknown

Pulmonary Tuberculosis and Vitamin D

Tuberculosis

India
Maulana Azad Medical College

Completed

Prospective Study of N-acetyltransferase2 (NAT2) and Cytochrome P4502E1 (CYP2E1) Gene as Susceptible Risk Factors for Antituberculosis (ATT) Induced Hepatitis

Pulmonary Tuberculosis

India
Ministry of Science and Technology, India

Completed

Efficacy and Safety of Immunomodulator as an Adjunct Therapy in New Pulmonary Tuberculosis(Category I) Patients.

Tuberculosis

India
National Institute of Allergy and Infectious Diseases...

Completed

A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.

HIV Infections | Tuberculosis

United States
All India Institute of Medical Sciences, New Delhi

Unknown

Comparison Between Efficacy of Daily and Intermittent Low Glycemic Index Therapy Diet

Drug Resistant Epilepsy

India
All India Institute of Medical Sciences, New Delhi

Unknown

Dietary Therapy In Epilepsy Treatment (DIET-Trial): A Randomised Non Inferiority Trial Comparing KD, MAD & LGIT for Drug Resistant Epilepsy (DIET)

Drug Resistant Epilepsy

India
Ministry of Science and Technology, India

Completed

Efficacy and Safety Study of Immunomodulator as an Adjunct Therapy in Pulmonary Tuberculosis (TB) Retreatment Patients

Tuberculosis

India
Centers for Disease Control and Prevention
US Department of Veterans Affairs

Completed

TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis

Pulmonary Tuberculosis

United States, Canada
NYU Langone Health

Completed

Evaluation of the Practice of Three Morning Sputa on Separate Days for Diagnosis of Mtb

Pulmonary TB

United States
All India Institute of Medical Sciences, New Delhi

Unknown

Comparison of Efficacy of LGIT and MAD Among Children With Drug Resistant Epilepsy

Drug Resistant Epilepsy | Ketogenic Dieting

India
Lady Hardinge Medical College

Completed

Efficacy of a Simplified Modified Atkins Diet in Children With Refractory Epilepsy (SMAD)

Refractory Epilepsy

India
All India Institute of Medical Sciences, New Delhi

Completed

Dietary Therapy in Children With Refractory Epilepsy

Epilepsy

India
Lady Hardinge Medical College

Completed

Evaluation of the Modified Atkins Diet in Young Children With Refractory Epilepsy

Refractory Epilepsy

India
All India Institute of Medical Sciences, New Delhi

Unknown

Low Glycemic Index Diet Therapy in Children With Refractory Epilepsy

Refractory Epilepsy

India
Centers for Disease Control and Prevention
Sanofi

Completed

TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment

Pulmonary Tuberculosis

Uganda, United States, South Africa, Brazil, Canada, Spain
IUATLD, Inc
Medical Research Council; Institute of Tropical Medicine, Belgium; Liverpool... and other collaborators

Completed

The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB (STREAM)

MDR-TB

Ethiopia, Georgia, India, Moldova, Republic of, Mongolia, South Africa, Uganda
National Institute of Allergy and Infectious Diseases...

Completed

A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin

HIV Infections | Tuberculosis

United States
UCB Biopharma S.P.R.L.

Completed

Study to Test the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adults With Drug-resistant Epilepsy (ARISE)

Focal-Onset Seizures | Drug-resistant Epilepsy

United States, Australia, Belgium, Bulgaria, Canada, Czechia, France, Germany, Hungary, Italy, Japan, Lithuania, Mexico, Poland, Portugal, Slovakia, Spain, Turkey, United Kingdom
University Hospital, Ghent
Research Foundation Flanders

Completed

Trial Comparing Different Stimulation Paradigms in Patients Treated With Vagus Nerve Stimulation for Refractory Epilepsy

Epilepsy

Belgium, United States
Global Alliance for TB Drug Development
Sanofi; University College, London; European and Developing Countries Clinical... and other collaborators

Completed

Controlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary Tuberculosis (REMoxTB)

Pulmonary Tuberculosis

China, Zambia, Tanzania, India, Kenya, Malaysia, Mexico, South Africa, Thailand
University of Pennsylvania
Columbia University; National Institute of Neurological Disorders and Stroke...

Enrolling by invitation

Memory Retrieval and Encoding Investigated by Neural Stimulation (MEMREINS)

Epilepsy Intractable

United States
UCB Biopharma SRL

Terminated

Study to Test the Safety and Efficacy of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy

Drug-Resistant Epilepsy | Focal-Onset Seizures

United States, Australia, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Japan, Lithuania, Mexico, Poland, Romania, Serbia, Slovakia, Spain, Turk... and more
University of Rochester
GlaxoSmithKline; Cornell University; American College of Clinical Pharmacy

Completed

The Effects of Omega-3 Fatty Acids on Aspirin Resistance

Increased Drug Resistance

United States
Madeline Fields

Recruiting

The Efficacy of a Subanesthetic Doses of IV Ketamine in the Treatment Drug Resistant Epilepsy

Drug Resistant Epilepsy | Refractory Epilepsy | Medically Refractory Epilepsy

United States
Columbia University
GlaxoSmithKline; American Epilepsy Society; Milken Institute

Terminated

P-glycoprotein Inhibition as Adjunct Treatment for Medically Refractory Epilepsy.

Epilepsy

United States
UCB Biopharma SRL

Terminated

A Study to Test the Efficacy and Safety of Padsevonil as Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy (DUET)

Drug-Resistant Epilepsy | Focal-Onset Seizures

United States, Australia, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Japan, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerlan... and more
All India Institute of Medical Sciences, New Delhi

Completed

Study of Safety and Efficacy of Different Regimes of Reintroduction of Anti-TB Drugs in Anti-TB Drugs Induced Liver Damage

Tuberculosis | Drug Induced Hepatotoxicity

India
Dartmouth-Hitchcock Medical Center
National Institute of Mental Health (NIMH)

Completed

Modulation of Emotion Perception in Humans Via Amygdala Stimulation

Refractory Epilepsy

United States
Marinus Pharmaceuticals

Terminated

A Two-year Open-label Extension Study of Ganaxolone in Patients With Drug-resistant Partial-onset Seizures

Drug Resistant Partial Onset Seizure

United States
Kessler Foundation
NYU Langone Health

Unknown

Feasibility of HOBSCOTCH Telehealth Intervention in Refractory Epilepsy (HOBSCOTCH)

Refractory Epilepsy

United States
Archivel Farma S.L.

Recruiting

Clinical Trial to Investigate Therapeutic Vaccine (RUTI) Against Tuberculosis (TB)

Tuberculosis, Pulmonary

India
Global Alliance for TB Drug Development

Completed

Study to Evaluate Safety, Tolerability, and the PK Profile of TBI-223 in Healthy Subjects

Tuberculosis | Tuberculosis, Pulmonary

United States
Centers for Disease Control and Prevention
Tuberculosis Trials Consortium

Recruiting

Short-course Regimens for the Treatment of Pulmonary Tuberculosis (CRUSH-TB)

Tuberculosis, Pulmonary | Tuberculosis Infection

Canada, United States, Haiti, South Africa, Uganda, Vietnam
Marinus Pharmaceuticals

Completed

Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension

Drug Resistant Partial Onset Seizure

United States, Australia, Russian Federation, Bulgaria, Germany, Poland
Monteris Medical

Terminated

Feasibility Study on LITT for Medical Refractory Epilepsy

Epilepsy

United States
Louisiana State University Health Sciences Center...

Unknown

Pilot Trial to Evaluate The Effect of Oral Methylprednisolone on Seizure Frequency in Children With Epilepsy

Intractable Epilepsy | Convulsive Seizures

United States
Foundation for Innovative New Diagnostics, Switzerland

Completed

Accuracy and Feasibility of Xpert Ultra

Tuberculosis, Pulmonary

Belarus, Georgia, India, South Africa
Maimonides Medical Center

Completed

Clinical and Microbiological Outcomes of Infections Due to Carbapenem-Resistant Gram-Negative Bacteria

Drug Resistance, Microbial

United States
Acorda Therapeutics

Terminated

Bioavailability, Safety and Tolerability of Diazepam Nasal Spray Versus Diazepam Rectal Gel (Diastat®)

Refractory Epilepsy

United States
Centers for Disease Control and Prevention

Completed

TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment

Tuberculosis, Pulmonary

Uganda, United States, Canada, South Africa
Cerebral Therapeutics LLC

Terminated

Study to Assess Intracerebroventricular (ICV) Delivery of CT-010 in Subjects With Focal Seizures, With Temporal Lobe Onset With or Without Secondary Generalization

Refractory Epilepsy

Israel, Australia
University College, London
National University Hospital, Singapore; Singapore Clinical Research Institute...

Completed

Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for Drug-sensitive Tuberculosis (TRUNCATE-TB)

Tuberculosis, Pulmonary

Singapore, Uganda, Thailand, Indonesia, Philippines, India

Clinical Trials on Pulmonary Multi-drug Resistant Tuberculosis in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations